A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

October 23, 2013

Primary Completion Date

April 15, 2016

Study Completion Date

April 15, 2016

Conditions
Heterozygous Familial Hypercholesterolemia
Interventions
DRUG

Bococizumab (PF-04950615;RN316)

150 mg every 2 weeks, subcutaneous injection, 12 months

OTHER

Placebo

subcutaneous injection every 2 weeks for 12 months

Trial Locations (88)

1202

Second MHAT - Sofia EAD, Sofia

1685

Midrand Medical Centre, Halfway House

1709

"MHAT Sveta Anna, Clinic of Internal Diseases", Sofia

1724

Roodepoort Medicross Clinical Research Centre, Roodepoort

4001

Chelmsford Medical Centre 3, Durban

4002

"UMHAT Sveti Georgi EAD, Clinic of Cardiology", Plovdiv

5800

SHAT in Cardiology EAD, Pleven

7130

Synexus Helderberg Clinical Research Centre, Somerset West

7500

TREAD Research cc., Parow, Cape Town

7530

Tiervlei Trial Centre, Karl Bremer Hospital, Bellville, Cape Town

9301

IATROS International, Bloemfontein

14004

Hospital Universitario Reina Sofia, Córdoba

15706

Hospital Clinico Universitario, Santiago de Compostela, Santiago de Compostela

19107

Thomas Jefferson University, Philadelphia

20520

Division of Medicine Turku University Hospital, Turku

21100

Ospedale di Circolo e Fondazione Macchi, Varese

22015

Burke Internal Medicine & Research, Burke

28007

Hospital General Universitario Gregorio Maranon, Madrid

28040

Fundacion Jimenez Diaz; Servicio de Medicina Interna, Madrid

Hospital Clinico San Carlos; U. de Lipidos; Medicina Interna III, Madrid

29340

OnSite Clinical Solutions, LLC, Gaffney

33016

Best Quality Research, Inc., Hialeah

33140

NewPhase Clinical Trials, Corp., Miami Beach

33144

Medical Research Center, Miami

33165

Premier Research Associate, Inc, Miami

33174

Columbus Clinical Services, LLC, Miami

41013

Hospital Universitario Virgen del Rocio, Seville

43204

Hospital Universitario Sant Joan de Reus, Reus

45227

Metabolic and Atherosclerosis Research Center, Cincinnati

50009

Hospital Clinico Universitario Miguel Servet; Medicina Interna, Zaragoza

73120

Oklahoma Heart Hospital Physicians, Oklahoma City

Oklahoma Heart Hospital Research Foundation, Oklahoma City

Oklahoma Heart Hospital, Oklahoma City

75251

Galenos Research, Dallas

75390

UT Southwestern Medical Center, Dallas

77099

Pioneer Research Solutions, Inc., Houston

77479

Pioneer Research Solutions, Inc., Sugar Land

80100

Pohjois-Karjala Projekti Saatio/Ita-Suomen, Joensuu

Pohjois-Karjala Projekti Saatio, Joensuu

80131

"Azienda Ospedaliero Universitaria Federico II di Napoli", Napoli

84020

Focus Clinical Research, LLC, Draper

89119

Om Medical, Las Vegas

90020

IMD Medical Group, Los Angeles

90127

"Policlinico Paolo Giaccone", Palermo

90220

Oulu University Hospital, Oulu

06102

Hartford Hospital, JB704, Hartford

27599-7075

The University of North Carolina at Chapel Hill Center for Heart & Vascular Care, Chapel Hill

27599-7600

The University of North Carolina Hospitals - Clinical and Translational Research Center Clinic, Chapel Hill

V6Z 1Y6

St. Paul's Hospital, Healthy Heart, Vancouver

V8T 5G4

Discovery Clinical Services Ltd., Victoria

R2H 2A6

Asper Clinical Research Institute, Winnipeg

A1B 3V6

Health Sciences Centre, St. John's

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

G7H 7K9

Ecogene-21, Chicoutimi

H1T 1C8

Montreal Heart Institute, Montreal

H2W 1R7

Institut de Recherches Cliniques de Montreal, Montreal

G1V 4W2

Clinique des maladies lipidiques de Quebec Inc, Québec

00014

Helsinki Central University Hospital, Helsinki

04200

Laakarikeskus Aava Kerava/Aava Kerava Medical Center, Kerava

06156

"Ospedale Santa Maria della Misericordia", Perugia

3045 PM

St. Franciscus Gasthuis, Rotterdam

4462 RA

Admiraal de Ruyter ziekenhuis, Goes

1105 AZ

Academic Medical Center, Amsterdam

4818 CK

Amphia Hospital, Breda

7416 SE

Deventer Ziekenhuis, Deventer

3039 BD

Rotterdam Research Institute, Rotterdam

3361 XV

Albert Schweitzer Hospital, Sliedrecht

2545 CH

Hagaziekenhuis, The Hague

3584 CX

UMC Utrecht, Utrecht

0373

Oslo Universitetssykehus HF, Oslo

0450

Oslo Universitetssykehus HF, Ulleval, Oslo

85-079

NZOZ Vitamed, Bydgoszcz

31-567

NZOZ Centrum Zdrowia i Profilaktyki Dabie Sp zo.o., Krakow

41-709

NZOZ Przychodnia Specjalistyczna Andrzej Wittek Henryk Rudzki S.C, Ruda Śląska

0157

Unitas hospital, Centurion

0158

Medipark Centre for Clinical Research, Pretoria

0183

Jongaie Research, Pretoria

0184

Synexus Watermeyer Clinical Research Centre, Pretoria

08907

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

08036

Hospital Clinic, Barcelona

M13 9WL

Clinical Trials Pharmacy, 4th Floor Inpatient Pharmacy, Manchester

Central Manchester University Hospitals NHS Foundation Trust, Manchester

OL1 2JH

Pennine Acute Hospitals NHS Trust, Oldham

SG1 4AB

East and North Hertfordshire NHS Trust, Stevenage

DE13 0RB

Burton Hospitals NHS Foundation Trust, Burton-on-Trent

B9 5SS

Heart of England NHS Foundation Trust, Birmingham

NW3 2QG

Royal Free London NHS Foundation Trust, London

PE3 9GZ

Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01968980 - A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia | Biotech Hunter | Biotech Hunter